ARKGARK Genomic Revolution ETF
Grow my money#713 of 2944 for Grow my money
Seeks long-term growth of capital.
ARK ETF Trust · Since 2014 (11 years)
Annual Cost
0.75%
#3579 out of 5,332 ETFs
Fund Size
$1.0B
#990 out of 5,332 ETFs
Dividend Yield
0.00%
Track Record
11 years
#1246 out of 5,332 ETFs
Performance
1 Year
+37.8%
3 Years
+1.8%
5 Years
-19.9%
What's inside
Asset class
Focus
Biotech & Genomics
Asset allocation
Stocks
99.9%
Cash
0.1%
Sector breakdown
Healthcare
100.0%
Top holdings
CRISPR Therapeutics AGCRSP9.2%
Twist Bioscience CorpTWST9.0%
Tempus AI Inc Class A common stockTEM8.7%
10x Genomics Inc Ordinary Shares - Class ATXG6.3%
Beam Therapeutics IncBEAM4.9%
Personalis IncPSNL4.7%
Natera IncNTRA4.5%
Illumina IncILMN4.4%
Guardant Health IncGH4.2%
Intellia Therapeutics IncNTLA3.6%
Risk profile
Volatility (1Y)
42.0%
High
Max drawdown
-83.6%
Worst peak-to-trough loss
Sharpe (3Y)
0.17
Below average
Sortino (3Y)
0.25
Moderate downside risk
Similar ETFs
Data updated on 2026-05-05